IEC 60601-1-2

IEC 60601-1-2 is the electromagnetic-compatibility collateral standard within the IEC 60601 family. It addresses the basic safety and essential performance of medical electrical equipment and medical electrical systems when exposed to electromagnetic disturbances. It also addresses electromagnetic disturbances generated by that equipment.

The standard supplements IEC 60601-1 rather than replacing it. Product-specific particular standards, other collateral standards, risk-management requirements, and regional regulatory rules may introduce additional or modified requirements.

The compliance strategy is based on the intended electromagnetic environment. Typical classifications include professional healthcare facilities, home healthcare environments, and special environments. A special environment may require test levels or mitigation measures derived from a product-specific electromagnetic risk assessment.

Compliance is therefore more than completing a fixed list of laboratory tests. The manufacturer must identify essential performance, define observable pass/fail criteria, document intended operating environments, evaluate foreseeable electromagnetic disturbances, and demonstrate that unacceptable risks are adequately controlled.

The standard applies broadly to medical electrical equipment and medical electrical systems covered by the IEC 60601 series. Examples may include patient monitors, diagnostic instruments, therapeutic equipment, infusion systems, ventilatory equipment, imaging-system components, electrically powered hospital equipment, and medical devices intended for home use.

Accessories, external power supplies, cables, sensors, network interfaces, wireless modules, and interconnected equipment can affect the final EMC configuration. The tested configuration should therefore represent the marketed system and include the equipment, accessories, cable types, cable lengths, operating modes, and supporting equipment that can create the highest emissions or greatest susceptibility.

Applicability must be established from the product definition and the relevant regulatory pathway. Some products, such as certain in-vitro diagnostic equipment, implantable equipment, laboratory equipment, or non-medical accessories, may be governed primarily by other standards. A product-specific standards assessment should be completed before the test plan is finalized.

International use: IEC 60601-1-2 is an international consensus standard. It becomes legally or contractually relevant when adopted by a regulator, incorporated into a regional standard, required by a certification scheme, or specified by a purchaser. Manufacturers should identify the exact edition and amendments accepted in every target market.

United States: The U.S. Food and Drug Administration recognizes IEC 60601-1-2 Edition 4.1 as a consensus standard, subject to the extent and qualifications stated in the FDA recognition database. The FDA record identifies partial-recognition conditions, so manufacturers should not assume that an unqualified IEC test report addresses every FDA expectation. Current FDA EMC guidance and device-specific requirements should also be considered.

European Union: Manufacturers should confirm the applicable EN adoption, its current harmonization status, and any dates or restrictions listed for the Medical Device Regulation or other relevant legislation. Use of a harmonized standard can support a presumption of conformity only within its published scope and conditions.

Canada: EMC evidence forms part of the overall safety and effectiveness documentation for applicable medical devices. Manufacturers should verify the edition accepted for their submission, the applicable device classification, and any additional Health Canada expectations.

Regional deviations, national adoptions, product-specific standards, radio requirements, and cybersecurity or wireless-coexistence expectations may apply in addition to IEC 60601-1-2.

The required test plan is determined by the equipment ports, power interfaces, intended environment, operating modes, essential performance, and electromagnetic risk analysis. A typical evaluation can include the following groups.

Electromagnetic emissions

• Conducted disturbance measurements at AC mains and other applicable wired ports.
• Radiated electromagnetic disturbance measurements.
• Mains harmonic-current and voltage-fluctuation or flicker assessments when applicable.
• Additional emissions requirements arising from wireless transmitters, particular standards, or regional regulations.

Electromagnetic immunity

• Electrostatic discharge under IEC 61000-4-2.
• Radiated RF electromagnetic-field immunity under IEC 61000-4-3.
• Immunity to proximity fields from RF wireless communications equipment.
• Electrical fast transient and burst testing under IEC 61000-4-4.
• Surge immunity under IEC 61000-4-5.
• Conducted RF immunity under IEC 61000-4-6.
• Power-frequency magnetic-field immunity under IEC 61000-4-8.
• Proximity magnetic-field immunity where applicable.
• Voltage dips, short interruptions, and voltage variations under IEC 61000-4-11 or the applicable power-port method.

Additional tests may be required by a particular medical-device standard, the intended special environment, the product risk analysis, national deviations, or the regulatory authority reviewing the device.

Common measurement and immunity ranges include conducted emissions from approximately 150 kHz to 30 MHz, radiated emissions beginning at approximately 30 MHz, conducted RF immunity from approximately 150 kHz to 80 MHz, and radiated RF immunity above approximately 80 MHz. The actual upper measurement frequency depends on the equipment characteristics and the applicable emissions standard.

IEC 60601-1-2 also addresses selected wireless-communications frequency bands using proximity-field tests. These tests are applied at defined frequencies, modulations, distances, and field strengths intended to represent nearby communications equipment. Amendment 1 also introduced or updated provisions relevant to proximity magnetic fields.

Frequently encountered baseline examples include electrostatic-discharge testing up to ±8 kV by contact and ±15 kV through air, and radiated-immunity levels that may be 3 V/m or 10 V/m depending on the intended environment. Higher levels can apply at selected wireless proximity frequencies or where justified by a special environment. These values are not a complete test specification and should not be used without consulting the applicable edition and regional adoption.

Emissions limits are commonly derived from CISPR 11 classifications and depend on factors such as equipment group, Class A or Class B designation, test site, measurement distance, port type, detector, and frequency range. Equipment intended for residential or home-healthcare use will generally face more restrictive emissions expectations than equipment intended only for controlled non-residential locations.

Immunity compliance is not represented by a single limit line. The equipment is exposed to defined disturbance levels while its basic safety and essential performance are monitored against documented pass/fail criteria. Temporary degradation may be acceptable only when it is consistent with the manufacturer-defined criteria, does not create unacceptable risk, and is allowed by the applicable requirement.

Exact numerical limits, test levels, frequency steps, dwell times, modulation parameters, coupling methods, exclusions, and permitted performance behavior must be taken from the licensed official standard, applicable amendments, referenced basic standards, and relevant national or regional adoption.

The equipment under test should represent the final marketed configuration. The test plan should identify the hardware and software versions, accessories, cables, patient connections, power supplies, networking equipment, wireless functions, loads, simulators, and supporting equipment used during evaluation.

Operating modes should be selected to exercise the functions most likely to produce maximum emissions and the functions most vulnerable to electromagnetic disturbances. Where one operating state cannot represent all essential functions, multiple modes or separate test sequences may be necessary.

Before testing, the manufacturer should define objective pass/fail criteria for basic safety and each essential-performance function. Monitoring must be capable of detecting unacceptable degradation during and after exposure without materially disturbing the electromagnetic test setup.

Cable layout, cable length, grounding, enclosure configuration, peripheral placement, patient-coupled parts, and charging or communication states should be controlled and documented. Any deviation from the prescribed setup or test method should be technically justified and reported.

Important